I'm (almost) sure that Derek said, in one of the early (mid 2020) **promotion blocked** interviews, that after VIDRL validation of our test we would seek TGA approval and that the approval would be facilitated because of our association with Doherty. Subsequently, TGA approval would facilitate FDA approval.
Didn't/hasn't happen(ed).
Instead we went to UK for CE mark and saliva verification as our differentiator.
Great product, but we appear to have zigged and zagged our way from a near short term commercial certainty to a struggling long term possibility.
Never mind, so long as Covid finally enables our Eugeni POC platform technology we will eventually find our El Dorado, but fair way down the track from the early promise.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)